课题基金 / 基金详情

Minority Based Community Clinical Oncology Program

Minority Based Community Clinical Oncology Program
基于少数民族的社区临床肿瘤学计划
批准号:
7282269
负责人:
DAVID J PEACE
金额:
$70.5万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-15 至 2012-05-31

项目摘要

项目成果

DAVID J PEACE的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):1。保持非裔美国男性成功保留硒和维生素E硒和维生素E癌症预防试验(SELECT),并成功招募和保留非裔美国男性参加SELECT辅助研究。2.为少数群体个人提供最先进的癌症治疗,通过使用经过验证的招募和保留策略增加少数群体对癌症治疗方案的参与:3.通过与两个主要的NCI资助计划[人口健康与健康差异中心(CPHHD)和患者导航研究计划(PNRP)]和Ingalls卫生系统合作,提高整个芝加哥和西北印第安纳州地区提供的癌症预防和控制(CaP/C)机会的水平。UIC MB-CCOP计划利用这些伙伴关系建立一个结构和框架,以克服招聘和保留的障碍,并为整个地区的少数民族社区提供CaP/C试验。4.提高卫生保健提供者、社区领导人和地方组织对UIC MB-CCOP活动的认识、理解和参与。这些目标将通过UIC血液学/肿瘤学部门内建立的少数民族临床研究总部实现,并利用几个研究基地:癌症和白血病组B(CALGB):自1996年以来的主要成员西南肿瘤组(SWOG):CCOP扩大使用试点计划(1998)东部肿瘤协作组(ECOG):2005年7月15日接受(经NCI许可)妇科肿瘤组(GOG)国家外科辅助乳腺和肠道项目(NSABP):星星和P-4密歇根大学CCOP研究基地:CaP/C罗切斯特大学CCOP研究基地:CaP/C
英文摘要
DESCRIPTION (provided by applicant): 1. To maintain the successful retention of African-American men to the Selenium and Vitamin E Selenium and Vitamin E Cancer Prevention Trial (SELECT) and the successful recruitment and retention of African- American men to SELECT ancillary studies. 2. To provide access to state-of-the-art cancer treatment for minority individuals by increasing minority participation in cancer treatment protocols using proven recruitment and retention strategies: 3. To raise the level of cancer prevention and control (CaP/C) opportunities offered throughout the Chicago and Northwest Indiana region by partnering with two major NCI-funded programs [Center for Population Health and Health Disparities (CPHHD) and the Patient Navigator Research Program (PNRP)] and Ingalls Health System. The UIC MB-CCOP plans to leverage these partnerships to establish a structure and framework to overcome the barriers to recruitment and retention and provide access to CaP/C trials to minority communities in this entire region. 4. To increase the awareness, understanding, and involvement of health care providers, community leaders, and local organizations in UIC MB-CCOP activities. These aims will be achieved by an established minority clinical research headquarters within the UIC Section of Hematology/Oncology and utilizes several research bases: Cancer and Leukemia Group B (CALGB): Main Member since 1996 Southwest Oncology Group (SWOG): CCOP Expanded Access Pilot Program (1998) Eastern Cooperative Oncology Group (ECOG): Accepted July 15, 2005 (by NCI permission) Gynecologic Oncology Group (GOG) National Surgical Adjuvant Breast and Bowel Project (NSABP): STAR & P-4 The University of Michigan CCOP Research Base: CaP/C The University of Rochester CCOP Research Base: CaP/C
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Pilot Phase IB trial of PSA-Peptide Based Specific Active Immunotherapy
A PILOT PHASE IB TRIAL OF A PSA PEPTIDE VACCINE
A PILOT PHASE IB TRIAL OF A PSA PEPTIDE VACCINE
Minority Based Community Clinical Oncology Program
海外基金